HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.

AbstractOBJECTIVES:
To assess the efficacy of the Ginkgo biloba in patients with dementia of the Alzheimer type in slowing down the disease's degenerative progression and the patients' cognitive impairment compared with rivastigmine.
METHODS:
Total 56 patients aged 50-75 years, suffering from dementia, were allocated into one of the two treatments: group 1) Ginkgo biloba (120 mg daily dose); group 2) rivastigmine (4.5 mg daily dose) in a 24-week randomized double blind study. The degree of severity of dementia was assessed by the Seven Minute test and the Mini-Mental State Examination.
RESULTS:
Our results confirm the clinical efficacy of rivastigmine in the dementia of the Alzheimer type, comparing to Ginkgo biloba. There are few published trials that have directly compared a cholinesterase inhibitor with Ginkgo for dementia. This study directly compares a cholinesterase inhibitor with Ginkgo biloba for dementia of the Alzheimer type.
CONCLUSION:
Our study suggests that there are differences in the efficacy of Ginkgo biloba and rivastigmine in the treatment of Alzheimer's dementia. In addition, this study suggested that cholinesterase inhibitors should be used in preference to Ginkgo biloba in patients with mild to moderate AD.
AuthorsNastaran Majdi Nasab, Mohammad Ali Bahrammi, Mohammad Reza Amiri Nikpour, Fakher Rahim, Sayed Navid Naghibis
JournalJPMA. The Journal of the Pakistan Medical Association (J Pak Med Assoc) Vol. 62 Issue 7 Pg. 677-80 (Jul 2012) ISSN: 0030-9982 [Print] Pakistan
PMID23866514 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cholinesterase Inhibitors
  • Phenylcarbamates
  • Rivastigmine
Topics
  • Aged
  • Alzheimer Disease (drug therapy)
  • Analysis of Variance
  • Cholinesterase Inhibitors (therapeutic use)
  • Disease Progression
  • Double-Blind Method
  • Female
  • Ginkgo biloba
  • Humans
  • Male
  • Middle Aged
  • Phenylcarbamates (therapeutic use)
  • Phytotherapy
  • Rivastigmine
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: